Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Lactate administration improves laboratory parameters in murine models of iron overload

Wei Liu, Yue Wu, Huaiqing Wei, Juan Ma, Wenya Feng, Qiuyuan Yang, Shuping Zhang, Tomas Ganz, Sijin Liu

Blood (2024) 143 (11): 1045–1049.

https://doi.org/10.1182/blood.2023021695

Published: 2024

Includes: Supplemental data

Journal Articles

Complete Remission with Incomplete Count Recovery (CRi) Prior to sUCBT Is Associated with High Graft Failure in Acute Leukaemia Patients over 14 Years of Age

Yue Wu, Guangyu Sun, Baolin Tang, Kaidi Song, Xiaoyu Zhu

Blood (2023) 142 (Supplement 1): 7102.

https://doi.org/10.1182/blood-2023-178153

Published: 2023

Journal Articles

Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia after Umbilical Cord Blood Transplantation

Aijie Huang, Guangyu Sun, Baolin Tang, Kaidi Song, Yaxin Cheng, Meijuan Tu, Yue Wu, Tianzhong Pan, Dongyao Wang, Xiaoyu Zhu

Blood (2023) 142 (Supplement 1): 6976.

https://doi.org/10.1182/blood-2023-180621

Published: 2023

Journal Articles

A Predictive Model Combining Clinical Characteristics and Nutritional Risk Factors for Overall Survival after Umbilical Cord Blood Transplantation

Meijuan Tu, Aijie Huang, Lijuan Ning, Baolin Tang, Chunli Zhang, Guangyu Sun, Xiang Wan, Kaidi Song, Wen Yao, Ping Qiang, Yue Wu, Xiaoyu Zhu

Blood (2023) 142 (Supplement 1): 7097.

https://doi.org/10.1182/blood-2023-180705

Published: 2023

Journal Articles

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Lianna J. Marks, Kathleen McCarten, Qinglin Pei, Yue Wu, Kara M. Kelly, Cindy Schwartz, Suzanne Wolden, Debra L. Friedman, Sharon M. Castellino, Burton Appel

Blood (2023) 142 (Supplement 1): 1699.

https://doi.org/10.1182/blood-2023-179465

Published: 2023

Journal Articles

Letermovir Prophylaxis Reduced Cytomegalovirus Reactivation and Resistance Post Umbilical Cord Blood Transplantation

Bingbing Yan, Baolin Tang, Aijie Huang, Yue Wu, Guangyu Sun, Kaidi Song, Tianzhong Pan, Xiaoyu Zhu

Blood (2023) 142 (Supplement 1): 7098.

https://doi.org/10.1182/blood-2023-181514

Published: 2023

Journal Articles

Double-Negative T Cells Attenuate Acute Graft-Versus-Host Disease By Modulating CD4 + T Cell Activation Post-Allo-HSCT

Tianzhong Pan, Aijie Huang, Baolin Tang, Kaidi Song, Guangyu Sun, Yue Wu, Dongyao Wang, Xiaoyu Zhu

Blood (2023) 142 (Supplement 1): 4939.

https://doi.org/10.1182/blood-2023-182920

Published: 2023

Journal Articles

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Blood (2023) 142 (Supplement 1): 3084.

https://doi.org/10.1182/blood-2023-189652

Published: 2023

Journal Articles

Evaluating CHIPS in Pediatric High Risk Hodgkin Lymphoma Treated on AHOD1331

Cindy L Schwartz, Qinglin Pei, Frank G. Keller, Steve Y Cho, David C. Hodgson, Kathleen M McCarten, Yue Wu, Kara M. Kelly, Sharon M. Castellino

Blood (2022) 140 (Supplement 1): 6565–6566.

https://doi.org/10.1182/blood-2022-167188

Published: 2022

Journal Articles

Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study

Susan K. Parsons, Frank G. Keller, Qinglin Pei, Angie Mae Rodday, Jennifer Belsky, Yue Wu, Angela Punnett, Tara O Henderson, Kara M. Kelly, Sharon M. Castellino

Blood (2022) 140 (Supplement 1): 6550–6551.

https://doi.org/10.1182/blood-2022-167046

Published: 2022

Journal Articles

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

Akash Parekh, Frank G. Keller, Kathleen M. McCarten, Sandy Kessel, Steve Cho, Qinglin Pei, Yue Wu, Sharon M. Castellino, Louis S. Constine, Cindy L. Schwartz, David Hodgson, Kara M. Kelly, Bradford S. Hoppe

Blood (2022) 140 (10): 1086–1093.

https://doi.org/10.1182/blood.2022016098

Published: 2022

Includes: Supplemental data

Journal Articles

CAR-T Therapy Followed By Unrelated Cord Blood Transplantation for the Treatment of Children and Young Adults Relapsed/Refractory B-Cell ALL: Superior Survival but Relatively High Post-Transplant Relapse

Guangyu Sun, Baolin Tang, Xiang Wan, Wen Yao, Kaidi Song, Liangquan Geng, Ping Qiang, Yue Wu, Lijun Zhu, Dongyao Wang, Yun Wu, Huilan Liu, Zimin Sun, Xiaoyu Zhu

Blood (2021) 138 (Supplement 1): 4818.

https://doi.org/10.1182/blood-2021-152263

Published: 2021

Journal Articles

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Lisa Giulino-Roth, Qinglin Pei, Allen Buxton, Rizvan Bush, Yue Wu, Suzanne L. Wolden, Louis S. Constine, Kara M. Kelly, Cindy L. Schwartz, Debra L. Friedman

Blood (2021) 137 (11): 1449–1456.

https://doi.org/10.1182/blood.2020007225

Published: 2021

Includes: Supplemental data

Journal Articles

Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331

Hema Dave, Mimi Mai, Anushree Datar, Gaye Jenkins, BS, Qinglin Pei, PhD, Yue Wu, MS, Frank G. Keller, MD, Sharon M. Castellino, MD MSc, Terzah M Horton, MD PhD, Catherine M. Bollard, MD MBChB

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-136376

Published: 2020

Journal Articles

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Justine M. Kahn, MDMSc, Kara M. Kelly, MD, Qinglin Pei, PhD, Yue Wu, MS, Debra L. Friedman, MD, Tara O. Henderson, MD MPH, David C. Hodgson, MD MPH, FRCPC, Joel A. Kaplan, DO, MPH, Frank G. Keller, MD, Smita Bhatia, MDMPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138796

Published: 2020

Journal Articles

Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome

Blood (2016) 128 (22): 5536.

https://doi.org/10.1182/blood.V128.22.5536.5536

Published: 2016

Journal Articles

Intensified Myeloablative Conditioning Regimen without Antithymocytic (ATG) Results in Superior Patient Outcome Compared to Myeloablative Conditioning Regimen for Single-Unit Umbilical Cord Blood Transplantation in Hematological Malignancies

Zimin Sun, MD, Huilan Liu, Yue Wu, Changcheng Zheng, PhD, Baolin Tang, Xiaoyu Zhu, Qifa Liu

Blood (2016) 128 (22): 5837.

https://doi.org/10.1182/blood.V128.22.5837.5837

Published: 2016

Journal Articles

PECAM-1: a multifaceted regulator of megakaryocytopoiesis

Yue Wu, Thomas Welte, Michael Michaud, Joseph A. Madri

Blood (2007) 110 (3): 851–859.

https://doi.org/10.1182/blood-2006-05-022087

Published: 2007

NARROW

Lactate administration improves laboratory parameters in murine models of iron overload

Complete Remission with Incomplete Count Recovery (CRi) Prior to sUCBT Is Associated with High Graft Failure in Acute Leukaemia Patients over 14 Years of Age

Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia after Umbilical Cord Blood Transplantation

A Predictive Model Combining Clinical Characteristics and Nutritional Risk Factors for Overall Survival after Umbilical Cord Blood Transplantation

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Letermovir Prophylaxis Reduced Cytomegalovirus Reactivation and Resistance Post Umbilical Cord Blood Transplantation

Double-Negative T Cells Attenuate Acute Graft-Versus-Host Disease By Modulating CD4 + T Cell Activation Post-Allo-HSCT

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Evaluating CHIPS in Pediatric High Risk Hodgkin Lymphoma Treated on AHOD1331

Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

CAR-T Therapy Followed By Unrelated Cord Blood Transplantation for the Treatment of Children and Young Adults Relapsed/Refractory B-Cell ALL: Superior Survival but Relatively High Post-Transplant Relapse

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome

Intensified Myeloablative Conditioning Regimen without Antithymocytic (ATG) Results in Superior Patient Outcome Compared to Myeloablative Conditioning Regimen for Single-Unit Umbilical Cord Blood Transplantation in Hematological Malignancies

PECAM-1: a multifaceted regulator of megakaryocytopoiesis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only